Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | VCAN |
| Upstream (Parents) |
|---|
| (<<) CRTAP → VCAN |
| (<<) THY1 → VCAN |
| (<<) POSTN → VCAN |
| (<<) COL1A1 → VCAN |
| (<<) TAGLN → VCAN |
| (<<) FAP → VCAN |
| Downstream (Children) |
|---|
| VCAN → RBMS2 (>>) |
| VCAN → SNTB2 (>>) |
| VCAN → MAN2A1 (>>) |
| VCAN → DFFB (>>) |
| VCAN → GUCY1B3 (>>) |
| VCAN → CD55 (>>) |
| VCAN → MIR21 (>>) |
| VCAN → CD99 (>>) |
| VCAN → SMYD3 (>>) |
| VCAN → TAF5 (>>) |
| VCAN → CEP72 (>>) |
| VCAN → ASXL1 (>>) |
| VCAN → COL15A1 (>>) |
| VCAN → C4orf3 (>>) |
| VCAN → SCRN1 (>>) |
| VCAN → FERMT2 (>>) |
| VCAN → NPM1 (>>) |
| VCAN → CST1 (>>) |
| VCAN → POSTN (>>) |
| VCAN → TAGLN (>>) |
| VCAN → LAMB1 (>>) |
| VCAN → NRP1 (>>) |
| VCAN → SMARCA1 (>>) |
| VCAN → TIMP1 (>>) |
